Application and Revision of Montreal Cognitive Assessment in Chinese Retirees

The study was designed to employ MOCA to screen mild cognitive impairment (MCI) in military retirees and to analyze the associated risk factors. As such, MOCA was revised to be validated for the Chinese context.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Mild Cognitive Impairment Cognition Disorders Cognitive Dysfunction Mental Disorders Neurocognitive Disorders

Age range

60 year and older

Sex eligibility

All sexes

Study type

Observational

About this study

Three hundred and four retired military cadres were investigated using a random cluster sampling technique including personal information, prevalence, MOCA scale, and related neuropsychiatry scale. Thirty retirees were random chosen and tested again with the revised MOCA scale one month later.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

aged >=60 years old retired military cadres lived in Xian,Shaanxi,China questionnaires completed

Exclusion criteria

deaf-mute

Treatment and study plan

Primary outcomes

MCI occurrence rate

Time frame: up to 8 months

Three hundred and four retired military cadres from 9 Xi'an military sanatoria were investigated，assessed up to 8 months

Sponsors and collaborators

Lead sponsor

Xijing Hospital

Other

Registry information

Official study title

Application and Revision of Montreal Cognitive Assessment in Military Retirees With Mild Cognitive Impairment

Acronym: ARMOCA

Important dates

Study start: 2011
Primary completion: 2011
Study completion: 2014
First posted: Jun 29, 2015
Registry last updated: Jan 26, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed